No data available.
Please log in to see this content.
You have no subscription access to this content.
No metrics data to plot.
The attempt to load metrics for this article has failed.
The attempt to plot a graph for these metrics has failed.
Significant dose can be lost by extended delivery times in IMRT with x rays but not high-LET radiations
1.C. Nutting, D. P. Dearnaley, and S. Webb, “Intensity modulated radiation therapy: A clinical review,” Br. J. Radiol. 73, 459–469 (2000).
2.S. X. Chang, T. J. Cullip, and K. M. Deschesne, “Intensity modulation delivery techniques: ‘Step & shoot’ MLC auto-sequence versus the use of a modulator,” Med. Phys. 27, 948–959 (2000).
3.C. S. Chui, M. F. Chan, E. Yorke, S. Spirou, and C. C. Ling, “Delivery of intensity-modulated radiation therapy with a conventional multileaf collimator: Comparison of dynamic and segmental methods,” Med. Phys. 28, 2441–2449 (2001).
4.P. Alaei, P. D. Higgins, R. Weaver, and N. Nguyen, “Comparison of dynamic and step-and-shoot intensity-modulated radiation therapy planning and delivery,” Med. Dosim. 29, 1–6 (2004).
5.J. S. Welsh, J. P. Limmer, S. P. Howard, D. Diamond, P. M. Harari, and W. Tome, “Precautions in the use of intensity-modulated radiation therapy,” Technol. Cancer Res. Treat. 4, 203–210 (2005).
10.J. Z. Wang, X. A. Li, W. D. D’Souza, and R. D. Stewart, “Impact of prolonged fraction delivery times on tumor control: A note of caution for intensity-modulated radiation therapy (IMRT),” Int. J. Radiat. Oncol., Biol., Phys. 57, 543–552 (2003).
11.S. A. Roberts, J. H. Hendry, R. Swindell, J. M. Wilkinson, and R. D. Hunter, “Compensation for changes in dose-rate in radical low-dose-rate brachytherapy: A radiobiological analysis of a randomised clinical trial,” Radiother. Oncol. 70, 63–74 (2004).
12.X. K. Zheng, L. H. Chen, X. Yan, and H. M. Wang, “Impact of prolonged fraction dose-delivery time modeling intensity-modulated radiation therapy on hepatocellular carcinoma cell killing,” World J. Gastroenterol. 11, 1452–1456 (2005).
14.R. G. Dale, “The application of the linear-quadratic model to fractionated radiotherapy when there is incomplete normal tissue recovery between fractions, and possible implications for treatments involving multiple fractions per day,” Br. J. Radiol. 59, 919–927 (1986).
15.P. Nilsson, H. D. Thames, and M. C. Joiner, “A generalized formulation of the ‘incomplete-repair’ model for cell survival and tissue response to fractionated low dose-rate irradiation,” Int. J. Radiat. Biol. 57, 127–142 (1990).
16.W. T. Millar and P. A. Canney, “Derivation and application of equations describing the effects of fractionated protracted irradiation, based on multiple and incomplete repair processes. Part 1. Derivation of equations,” Int. J. Radiat. Biol. 64, 275–291 (1993).
17.P. A. Canney and W. T. Millar, “Biphasic cellular repair and implications for multiple field radiotherapy treatments,” Br. J. Radiol. 70, 817–822 (1997).
18.S. M. Bentzen, M. I. Saunders, and S. Dische, “Repair halftimes estimated from observations of treatment-related morbidity after CHART or conventional radiotherapy in head and neck cancer,” Radiother. Oncol. 53, 219–226 (1999).
19.S. M. Bentzen and M. C. Joiner, in Basic Clinical Radiobiology, edited by M. C. Joiner and A. J. van der Kogel (Hodder Arnold, London, 2009), pp. 120–134.
20.R. L. Maughan and M. Yudelev, “Physical characteristics of a clinical neutron therapy beam produced by a superconducting cyclotron,” Med. Phys. 22, 1459–1465 (1995).
21.P. R. Barber, B. Vojnovic, J. Kelly, C. R. Mayes, P. Boulton, M. Woodcock, and M. C. Joiner, “Automated counting of mammalian cell colonies,” Phys. Med. Biol. 46, 63–76 (2001).
22.B. Marples, B. G. Wouters, and M. C. Joiner, “An association between the radiation-induced arrest of G2 phase cells and low-dose hyper-radiosensitivity: A plausible underlying mechanism?,” Radiat. Res. 160, 38–45 (2003).
24.M. C. Joiner and A. J. van der Kogel, Basic Clinical Radiobiology (Hodder Arnold, London, 2009), p. 375.
25.M. C. Joiner, A. Rojas, and H. Johns, “A test of equal effect per fraction in the kidney of the mouse,” Radiat. Res. 130, 227–235 (1992).
28.S. H. Benedict, P. S. Lin, R. D. Zwicker, D. T. Huang, and R. K. Schmidt-Ullrich, “The biological effectiveness of intermittent irradiation as a function of overall treatment time: Development of correction factors for linac-based stereotactic radiotherapy,” Int. J. Radiat. Oncol., Biol., Phys. 37, 765–769 (1997).
29.X. Mu, P. O. Lofroth, M. Karlsson, and B. Zackrisson, “The effect of fraction time in intensity modulated radiotherapy: Theoretical and experimental evaluation of an optimisation problem,” Radiother. Oncol. 68, 181–187 (2003).
30.W. A. Tomé, J. Welsh, and J. F. Fowler, “The effect of fraction time in intensity modulated radiotherapy: Theoretical and experimental evaluation of an optimization problem (the real conclusions): In regard to Mu et al. Radiother Oncol 2003; 68: 181-187 [Letter],” Radiother. Oncol. 72, 113–114 (2004).
32.Y. Shibamoto, M. Ito, C. Sugie, H. Ogino, and M. Hara, “Recovery from sublethal damage during intermittent exposures in cultured tumor cells: Implications for dose modification in radiosurgery and IMRT,” Int. J. Radiat. Oncol. Biol. Phys. 59, 1484–1490 (2004).
33.F. Sterzing, M. W. Munter, M. Schafer, P. Haering, B. Rhein, C. Thilmann, and J. Debus, “Radiobiological investigation of dose-rate effects in intensity-modulated radiation therapy,” Strahlenther. Onkol. 181, 42–48 (2005).
34.S. B. Curtis, “Lethal and potentially lethal lesions induced by radiation—A unified repair model,” Radiat. Res. 106, 252–270 (1986).
36.L. Santanam, T. He, M. Yudelev, J. D. Forman, C. G. Orton, F. V. Heuvel, R. L. Maughan, and J. Burmeister, “Intensity modulated neutron radiotherapy for the treatment of adenocarcinoma of the prostate,” Int. J. Radiat. Oncol., Biol., Phys. 68, 1546–1556 (2007).
37.J. H. Hendry, S. M. Bentzen, R. G. Dale, J. F. Fowler, T. E. Wheldon, B. Jones, A. J. Munro, N. J. Slevin, and A. G. Robertson, “A modeled comparison of the effects of using different ways to compensate for missed treatment days in radiotherapy,” Clin. Oncol. 8, 297–307 (1996).
38.S. G. Williams, J. M. Taylor, N. Liu, Y. Tra, G. M. Duchesne, L. L. Kestin, A. Martinez, G. R. Pratt, and H. Sandler, “Use of individual fraction size data from 3756 patients to directly determine the alpha/beta ratio of prostate cancer,” Int. J. Radiat. Oncol., Biol., Phys. 68, 24–33 (2007).
39.J. R. Owen, A. Ashton, J. M. Bliss, J. Homewood, C. Harper, J. Hanson, J. Haviland, S. M. Bentzen, and J. R. Yarnold, “Effect of radiotherapy fraction size on tumour control in patients with early-stage breast cancer after local tumour excision: Long-term results of a randomised trial,” Lancet Oncol. 7, 467–471 (2006).
40.T. R. Mackie, T. Holmes, S. Swerdloff, P. Reckwerdt, J. O. Deasy, J. Yang, B. Paliwal, and T. Kinsella, “Tomotherapy: A new concept for the delivery of dynamic conformal radiotherapy,” Med. Phys. 20, 1709–1719 (1993).
42.M. Shaikh, J. Burmeister, M. C. Joiner, S. Pandya, B. Zhao, and Q. Liu, “Biological effect of different IMRT delivery techniques: SMLC, DMLC and helical tomotherapy,” Med. Phys. 37, 762–770 (2010).
Article metrics loading...
Full text loading...
Most read this month